Minor
Established
Descripción
Furosemide and spironolactone have complementary diuretic mechanisms that together provide more effective decongestion in heart failure; the primary concern is unpredictable electrolyte effects.
Mecanismo
Furosemide inhibits the NKCC2 transporter in the thick ascending limb, causing both sodium and potassium loss; spironolactone blocks aldosterone, promoting sodium excretion while retaining potassium. Net potassium effect is variable.
Relevancia clínica
This combination is guideline-recommended in refractory heart failure; hyperkalemia or hypokalemia may develop depending on dose ratio and renal function.
Manejo clínico
Monitor electrolytes (potassium, sodium, magnesium) and renal function closely, particularly during dose adjustments; target potassium 4.0–5.0 mEq/L.